SCHEMBL96238

SCHEMBL96238

[O]Cc1ccc(C(F)(F)F)cc1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.54
IDO1 P14902 4/20 0.52
KIF11 P52732 1/20 0.48
KMT2A Q03164 1/20 0.48
MAOB P27338 1/20 0.47
CES2 O00748 1/20 0.46
CES1 P23141 1/20 0.46
SRD5A2 P31213 1/20 0.46
ALDH1A1 P00352 2/20 0.45
KDM4E B2RXH2 1/20 0.45
MIF P14174 1/20 0.44
TSHR P16473 1/20 0.43
PTPN1 P18031 1/20 0.43
GSK3B P49841 1/20 0.43
PIK3CA P42336 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC8 Q9BY41 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2657293 0.82 TAAR1 (0.64) TAAR1IDO1KIF11MAOBALDH1A1
SCHEMBL1046741 0.80 TAAR1 (0.61) TAAR1IDO1KIF11KMT2AMAOB
SCHEMBL18242747 0.80 TAAR1 (0.35) TAAR1IDO1KIF11KMT2AMAOB
SCHEMBL7552818 0.80 TAAR1 (0.61) TAAR1IDO1KIF11MAOBALDH1A1
SCHEMBL3989285 0.79 TAAR1 (0.54) TAAR1IDO1KIF11KMT2AMAOB
SCHEMBL934227 0.78 TAAR1 (0.73) TAAR1IDO1MAOBALDH1A1KDM4E
SCHEMBL2096666 0.78 SRD5A2 (0.59) TAAR1IDO1KIF11KMT2AMAOB
SCHEMBL1047192 0.77 TAAR1 (0.57) TAAR1IDO1KIF11KMT2AMAOB
SCHEMBL18242251 0.77 TAAR1 (0.33) TAAR1IDO1KIF11KMT2ASRD5A2
SCHEMBL18856960 0.77 TAAR1 (0.57) TAAR1IDO1MAOBMIFPTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 923 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11796488-B2 Methods of preparing single-walled carbon nanotube networks ALLIANCE FOR SUSTAINABLE ENERGY, LLC (US) 2023-10-24 US claimed
CN-115925675-A Psamaplin A derivative and preparation method and application thereof 中国海洋大学 2023-04-07 CN claimed
CN-112679400-B Psamaplin A derivative and preparation method and application thereof 青岛海洋生物医药研究院股份有限公司 2022-10-04 CN claimed
US-20210164923-A1 METHODS OF PREPARING SINGLE-WALLED CARBON NANOTUBE NETWORKS Alliance for Energy Innovation, LLC 2021-06-03 US claimed
CN-112679400-A Psamaplin A derivative and preparation method and application thereof 青岛海洋生物医药研究院股份有限公司 2021-04-20 CN claimed
EP-3206488-B1 CURCUMIN ANALOGUES AS ZINC CHELATORS AND THEIR USES UNIV NEW YORK STATE RES FOUND (US) 2019-08-21 EP claimed
US-20180280367-A1 USE OF ANTHELMINTIC AGENTS AGAINST DIROFILARIA IMMITIS INTERVET INC. (US) 2018-10-04 US claimed
EP-3184569-B1 CURING INITIATORS FOR CATIONIC POLYMERIZATION FRAUNHOFER GES FORSCHUNG (DE) 2018-09-26 EP claimed
US-20170202816-A1 USE OF ANTHELMINTIC AGENTS AGAINST DIROFILARIA IMMITIS INTERVET INC. (US) 2017-07-20 US claimed
EP-3184569-A1 CURING INITIATORS FOR CATIONIC POLYMERIZATION Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) 2017-06-28 EP claimed
EP-0660827-B1 HETEROCYCLIC COMPOUNDS WITH PARASITICAL ACTIVITY ZENECA LTD (GB) 1997-04-16 EP claimed
US-5451594-A NEMATOCIDES, INSECTICIDES, MITICIDES AND FUNGICIDES ZENECA LIMITED (GB) 1995-09-19 US claimed
EP-0660830-A1 BENZOXAZOLE AND BEZOTHIAZOLE DERIVATIVES ZENECA LIMITED (GB) 1995-07-05 EP claimed
EP-0660827-A1 HETEROCYCLIC COMPOUNDS WIHT PARASITICAL ACTIVITY. ZENECA LTD (GB) 1995-07-05 EP claimed
CN-1098718-A Heterogeneous ring compound ZENECA LTD (GB) 1995-02-15 CN claimed
CN-1094400-A Heterogeneous ring compound ZENECA LTD (GB) 1994-11-02 CN claimed
WO-1994006777-A1 HETEROCYCLIC COMPOUNDS WIHT PARASITICAL ACTIVITY ZENECA LIMITED (GB) 1994-03-31 WO claimed
WO-1994006782-A1 BENZOXAZOLE AND BEZOTHIAZOLE DERIVATIVES ZENECA LIMITED (GB) 1994-03-31 WO claimed
WO-1994006783-A1 BENZOXAZOLE AND BENZOTHIAZOLE DERIVATIVES ZENECA LIMITED (GB) 1994-03-31 WO claimed
EP-0147052-A2 Rodenticides IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1985-07-03 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180280367-A1 USE OF ANTHELMINTIC AGENTS AGAINST DIROFILARIA IMMITIS MPO, DHODH, DHX35 TAAR1 4118/4885IDO1 238/4885KIF11 2552/4885
US-20170202816-A1 USE OF ANTHELMINTIC AGENTS AGAINST DIROFILARIA IMMITIS MPO, DHODH, DHX35 TAAR1 4118/4885IDO1 238/4885KIF11 2552/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.